WuXi Biologics (Cayman) Inc. (WXIBF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

WuXi Biologics (Cayman) I...

OTC: WXIBF · Real-Time Price · USD
5.61
0.25 (4.66%)
At close: Oct 03, 2025, 1:09 PM
5.36
-4.39%
After-hours: Oct 02, 2025, 12:07 PM EDT

WuXi Biologics (Cayman) Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
18.68B 17.03B 15.27B 10.29B
Cost of Revenue
11.02B 10.21B 8.54B 5.46B
Gross Profit
7.65B 6.83B 6.72B 4.83B
Operating Income
4.97B 4.45B 4.34B 3.19B
Interest Income
350.37M 219.18M 107.47M 58.03M
Pretax Income
4.83B 4.17B 5.36B 3.99B
Net Income
3.36B 3.4B 4.42B 3.39B
Selling & General & Admin
2.15B 1.79B 1.43B 1B
Research & Development
766.44M 792.58M 682.82M 501.58M
Other Expenses
-236.54M -204.23M 266.77M 138.62M
Operating Expenses
2.68B 2.38B 2.38B 1.64B
Interest Expense
157.59M 158.49M 64.38M 39.19M
Selling & Marketing Expenses
473.6M 294.01M 162.91M 124.65M
Cost & Expenses
13.7B 12.58B 10.93B 7.1B
Income Tax Expense
889.03M 603.18M 807.87M 484.54M
Shares Outstanding (Basic)
4.08B 4.16B 4.17B 4.4B
Shares Outstanding (Diluted)
4.23B 4.35B 4.38B 4.42B
EPS (Basic)
0.82 0.81 1.06 0.81
EPS (Diluted)
0.78 0.77 1.01 0.77
EBITDA
6.43B 5.5B 6.22B 4.51B
EBIT
4.99B 4.33B 5.42B 4.03B
Depreciation & Amortization
1.44B 1.17B 800.67M 481.78M